VF in the News

Pathway to Diagnosis (P2D) Plans an Innovative Study with the Goal of Reducing Delays in Diagnosis

P2D Objective Using big data to accurately predict a diagnosis using predictive analytics and machine learning methods. The Reality: Delays in diagnosis for patients with vasculitis Despite remarkable medical advances, diagnostic delays for patients with vasculitis remain extremely common and are a major cause of increased morbidity and mortality. This…...

Read more

Ohio State University Opens Multidisciplinary Vasculitis Clinic

by John Fries The Ohio State University Wexner Medical Center, a large academic medical center on the campus of The Ohio State University in Columbus, Ohio, has established an on-site Multidisciplinary Vasculitis Clinic to provide enhanced care for patients with vasculitis. The Clinic, which opened in December 2017 and is…...

Read more

2018 Kansas University Vasculitis Conference Includes Programs on Vasculitis Diagnosis, Medications and Research

by Suzanne DePaolis, Member, VF Board of Directors More than 60 participants attended the August 4, 2018, VF Vasculitis Educational Conference. On August 4, I had the pleasure of attending and speaking at the Kansas University – VF Vasculitis Educational Conference. I am an education junkie, so I love attending…...

Read more

VF 2018 Annual Appeal Invites Supporters to “Join Our Journey”

by Ed Becker, Director of Marketing and Communications Last year when the Vasculitis Foundation asked the vasculitis community to “dream big” the response was powerful, positive, and personal. Patients and caregivers from around the world shared their dreams about what they wanted to see that would bring hope, and real…...

Read more

FDA Clears Two PerkinElmer’s Assays to Help Diagnose ANCA-Associated Vasculitis

by Jose Marques Lopes, PhD The US Food and Drug Administration (FDA) cleared two assays to be used in the diagnosis of ANCA-associated vasculitis (AAV), according to PerkinElmer. Specifically, the FDA cleared the EUROPLUS Granulocyte Mosaic and the EUROIMMUN ANCA IFA — also referred to as EUROIMMUN IFA Granulocyte assays…...

Read more